Hertfordshire, United Kingdom

Stephen Edward Shanahan

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Edward Shanahan. Retrieved from https://idiyas.com/inventor/stephen-edward-shanahan-a7xouriv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen Edward Shanahan

Introduction

Stephen Edward Shanahan is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. His work is essential for advancing treatments for various medical conditions.

Latest Patents

Stephen holds a patent for naphthalene derivatives that bind to the EP4 receptor. This patent, which includes compounds of formula (I) and pharmaceutically acceptable derivatives, demonstrates high affinity for the EP4 receptor. These compounds are particularly useful in treating or preventing conditions such as pain, inflammation, immunological disorders, bone issues, neurodegenerative diseases, and renal disorders.

Career Highlights

Stephen is associated with SmithKline Beecham Corporation, where he has been instrumental in research and development. His innovative approach has led to advancements in pharmaceutical compounds that can significantly improve patient outcomes.

Collaborations

Stephen has worked alongside notable colleagues, including Gerard Martin Paul Giblin and Haydn Terence Jones. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Stephen Edward Shanahan's work in developing naphthalene derivatives showcases his commitment to innovation in the pharmaceutical industry. His contributions are vital for the advancement of treatments for numerous medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…